Jake Marcus

h-index4
2papers
578citations

2 Papers

53.4LGFeb 23, 2021
Do Transformer Modifications Transfer Across Implementations and Applications?

Sharan Narang, Hyung Won Chung, Yi Tay et al.

The research community has proposed copious modifications to the Transformer architecture since it was introduced over three years ago, relatively few of which have seen widespread adoption. In this paper, we comprehensively evaluate many of these modifications in a shared experimental setting that covers most of the common uses of the Transformer in natural language processing. Surprisingly, we find that most modifications do not meaningfully improve performance. Furthermore, most of the Transformer variants we found beneficial were either developed in the same codebase that we used or are relatively minor changes. We conjecture that performance improvements may strongly depend on implementation details and correspondingly make some recommendations for improving the generality of experimental results.

11.7LGAug 2, 2016Code
Multi-task Prediction of Disease Onsets from Longitudinal Lab Tests

Narges Razavian, Jake Marcus, David Sontag

Disparate areas of machine learning have benefited from models that can take raw data with little preprocessing as input and learn rich representations of that raw data in order to perform well on a given prediction task. We evaluate this approach in healthcare by using longitudinal measurements of lab tests, one of the more raw signals of a patient's health state widely available in clinical data, to predict disease onsets. In particular, we train a Long Short-Term Memory (LSTM) recurrent neural network and two novel convolutional neural networks for multi-task prediction of disease onset for 133 conditions based on 18 common lab tests measured over time in a cohort of 298K patients derived from 8 years of administrative claims data. We compare the neural networks to a logistic regression with several hand-engineered, clinically relevant features. We find that the representation-based learning approaches significantly outperform this baseline. We believe that our work suggests a new avenue for patient risk stratification based solely on lab results.